- call +1-201-465-4211
- email sales@mrinsights.biz
Human embryonic stem cell: also known as a human pluripotent stem cell, one of the "cells that are self-replicating, are derived from human embryos or human fetal tissue, and are known to develop into cells and tissues of the three primary germ layers.
Scope of the Report:
The worldwide market for Human Embryonic Stem Cells (HESC) is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Human Embryonic Stem Cells (HESC) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
ESI BIO
Thermo Fisher
BioTime
MilliporeSigma
BD Biosciences
Astellas Institute of Regenerative Medicine
Asterias Biotherapeutics
Cell Cure Neurosciences
PerkinElmer
Takara Bio
Cellular Dynamics International
Reliance Life Sciences
Research & Diagnostics Systems
SABiosciences
STEMCELL Technologies
Stemina Biomarker Discovery
Takara Bio
TATAA Biocenter
UK Stem Cell Bank
ViaCyte
Vitrolife
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Totipotent Stem Cells
Pluripotent Stem Cells
Unipotent Stem Cells
Market Segment by Applications, can be divided into
Research
Clinical Trials
Others
There are 15 Chapters to deeply display the global Human Embryonic Stem Cells (HESC) market.
Chapter 1, to describe Human Embryonic Stem Cells (HESC) Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Human Embryonic Stem Cells (HESC), with sales, revenue, and price of Human Embryonic Stem Cells (HESC), in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Human Embryonic Stem Cells (HESC), for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Human Embryonic Stem Cells (HESC) market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Human Embryonic Stem Cells (HESC) sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Human Embryonic Stem Cells (HESC) Introduction
1.2 Market Analysis by Type
1.2.1 Totipotent Stem Cells
1.2.2 Pluripotent Stem Cells
1.2.3 Unipotent Stem Cells
1.3 Market Analysis by Applications
1.3.1 Research
1.3.2 Clinical Trials
1.3.3 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 ESI BIO
2.1.1 Business Overview
2.1.2 Human Embryonic Stem Cells (HESC) Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 ESI BIO Human Embryonic Stem Cells (HESC) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Thermo Fisher
2.2.1 Business Overview
2.2.2 Human Embryonic Stem Cells (HESC) Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Thermo Fisher Human Embryonic Stem Cells (HESC) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 BioTime
2.3.1 Business Overview
2.3.2 Human Embryonic Stem Cells (HESC) Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 BioTime Human Embryonic Stem Cells (HESC) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 MilliporeSigma
2.4.1 Business Overview
2.4.2 Human Embryonic Stem Cells (HESC) Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 MilliporeSigma Human Embryonic Stem Cells (HESC) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 BD Biosciences
2.5.1 Business Overview
2.5.2 Human Embryonic Stem Cells (HESC) Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 BD Biosciences Human Embryonic Stem Cells (HESC) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Astellas Institute of Regenerative Medicine
2.6.1 Business Overview
2.6.2 Human Embryonic Stem Cells (HESC) Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Astellas Institute of Regenerative Medicine Human Embryonic Stem Cells (HESC) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Asterias Biotherapeutics
2.7.1 Business Overview
2.7.2 Human Embryonic Stem Cells (HESC) Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Asterias Biotherapeutics Human Embryonic Stem Cells (HESC) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Cell Cure Neurosciences
2.8.1 Business Overview
2.8.2 Human Embryonic Stem Cells (HESC) Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Cell Cure Neurosciences Human Embryonic Stem Cells (HESC) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 PerkinElmer
2.9.1 Business Overview
2.9.2 Human Embryonic Stem Cells (HESC) Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 PerkinElmer Human Embryonic Stem Cells (HESC) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Takara Bio
2.10.1 Business Overview
2.10.2 Human Embryonic Stem Cells (HESC) Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Takara Bio Human Embryonic Stem Cells (HESC) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Cellular Dynamics International
2.11.1 Business Overview
2.11.2 Human Embryonic Stem Cells (HESC) Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Cellular Dynamics International Human Embryonic Stem Cells (HESC) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Reliance Life Sciences
2.12.1 Business Overview
2.12.2 Human Embryonic Stem Cells (HESC) Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Reliance Life Sciences Human Embryonic Stem Cells (HESC) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Research & Diagnostics Systems
2.13.1 Business Overview
2.13.2 Human Embryonic Stem Cells (HESC) Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Research & Diagnostics Systems Human Embryonic Stem Cells (HESC) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 SABiosciences
2.14.1 Business Overview
2.14.2 Human Embryonic Stem Cells (HESC) Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 SABiosciences Human Embryonic Stem Cells (HESC) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 STEMCELL Technologies
2.15.1 Business Overview
2.15.2 Human Embryonic Stem Cells (HESC) Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 STEMCELL Technologies Human Embryonic Stem Cells (HESC) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Stemina Biomarker Discovery
2.16.1 Business Overview
2.16.2 Human Embryonic Stem Cells (HESC) Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Stemina Biomarker Discovery Human Embryonic Stem Cells (HESC) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 Takara Bio
2.17.1 Business Overview
2.17.2 Human Embryonic Stem Cells (HESC) Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Takara Bio Human Embryonic Stem Cells (HESC) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.18 TATAA Biocenter
2.18.1 Business Overview
2.18.2 Human Embryonic Stem Cells (HESC) Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 TATAA Biocenter Human Embryonic Stem Cells (HESC) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.19 UK Stem Cell Bank
2.19.1 Business Overview
2.19.2 Human Embryonic Stem Cells (HESC) Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 UK Stem Cell Bank Human Embryonic Stem Cells (HESC) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.20 ViaCyte
2.20.1 Business Overview
2.20.2 Human Embryonic Stem Cells (HESC) Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 ViaCyte Human Embryonic Stem Cells (HESC) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.21 Vitrolife
2.21.1 Business Overview
2.2.2 Human Embryonic Stem Cells (HESC) Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 Vitrolife Human Embryonic Stem Cells (HESC) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Human Embryonic Stem Cells (HESC) Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Human Embryonic Stem Cells (HESC) Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Human Embryonic Stem Cells (HESC) Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Human Embryonic Stem Cells (HESC) Manufacturer Market Share in 2017
3.3.2 Top 6 Human Embryonic Stem Cells (HESC) Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Human Embryonic Stem Cells (HESC) Market Analysis by Regions
4.1 Global Human Embryonic Stem Cells (HESC) Sales, Revenue and Market Share by Regions
4.1.1 Global Human Embryonic Stem Cells (HESC) Sales and Market Share by Regions (2013-2018)
4.1.2 Global Human Embryonic Stem Cells (HESC) Revenue and Market Share by Regions (2013-2018)
4.2 North America Human Embryonic Stem Cells (HESC) Sales and Growth Rate (2013-2018)
4.3 Europe Human Embryonic Stem Cells (HESC) Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Human Embryonic Stem Cells (HESC) Sales and Growth Rate (2013-2018)
4.5 South America Human Embryonic Stem Cells (HESC) Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Human Embryonic Stem Cells (HESC) Sales and Growth Rate (2013-2018)
5 North America Human Embryonic Stem Cells (HESC) by Countries
5.1 North America Human Embryonic Stem Cells (HESC) Sales, Revenue and Market Share by Countries
5.1.1 North America Human Embryonic Stem Cells (HESC) Sales and Market Share by Countries (2013-2018)
5.1.2 North America Human Embryonic Stem Cells (HESC) Revenue and Market Share by Countries (2013-2018)
5.2 United States Human Embryonic Stem Cells (HESC) Sales and Growth Rate (2013-2018)
5.3 Canada Human Embryonic Stem Cells (HESC) Sales and Growth Rate (2013-2018)
5.4 Mexico Human Embryonic Stem Cells (HESC) Sales and Growth Rate (2013-2018)
6 Europe Human Embryonic Stem Cells (HESC) by Countries
6.1 Europe Human Embryonic Stem Cells (HESC) Sales, Revenue and Market Share by Countries
6.1.1 Europe Human Embryonic Stem Cells (HESC) Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Human Embryonic Stem Cells (HESC) Revenue and Market Share by Countries (2013-2018)
6.2 Germany Human Embryonic Stem Cells (HESC) Sales and Growth Rate (2013-2018)
6.3 UK Human Embryonic Stem Cells (HESC) Sales and Growth Rate (2013-2018)
6.4 France Human Embryonic Stem Cells (HESC) Sales and Growth Rate (2013-2018)
6.5 Russia Human Embryonic Stem Cells (HESC) Sales and Growth Rate (2013-2018)
6.6 Italy Human Embryonic Stem Cells (HESC) Sales and Growth Rate (2013-2018)
7 Asia-Pacific Human Embryonic Stem Cells (HESC) by Countries
7.1 Asia-Pacific Human Embryonic Stem Cells (HESC) Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Human Embryonic Stem Cells (HESC) Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Human Embryonic Stem Cells (HESC) Revenue and Market Share by Countries (2013-2018)
7.2 China Human Embryonic Stem Cells (HESC) Sales and Growth Rate (2013-2018)
7.3 Japan Human Embryonic Stem Cells (HESC) Sales and Growth Rate (2013-2018)
7.4 Korea Human Embryonic Stem Cells (HESC) Sales and Growth Rate (2013-2018)
7.5 India Human Embryonic Stem Cells (HESC) Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Human Embryonic Stem Cells (HESC) Sales and Growth Rate (2013-2018)
8 South America Human Embryonic Stem Cells (HESC) by Countries
8.1 South America Human Embryonic Stem Cells (HESC) Sales, Revenue and Market Share by Countries
8.1.1 South America Human Embryonic Stem Cells (HESC) Sales and Market Share by Countries (2013-2018)
8.1.2 South America Human Embryonic Stem Cells (HESC) Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Human Embryonic Stem Cells (HESC) Sales and Growth Rate (2013-2018)
8.3 Argentina Human Embryonic Stem Cells (HESC) Sales and Growth Rate (2013-2018)
8.4 Colombia Human Embryonic Stem Cells (HESC) Sales and Growth Rate (2013-2018)
9 Middle East and Africa Human Embryonic Stem Cells (HESC) by Countries
9.1 Middle East and Africa Human Embryonic Stem Cells (HESC) Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Human Embryonic Stem Cells (HESC) Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Human Embryonic Stem Cells (HESC) Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Human Embryonic Stem Cells (HESC) Sales and Growth Rate (2013-2018)
9.3 UAE Human Embryonic Stem Cells (HESC) Sales and Growth Rate (2013-2018)
9.4 Egypt Human Embryonic Stem Cells (HESC) Sales and Growth Rate (2013-2018)
9.5 Nigeria Human Embryonic Stem Cells (HESC) Sales and Growth Rate (2013-2018)
9.6 South Africa Human Embryonic Stem Cells (HESC) Sales and Growth Rate (2013-2018)
10 Global Human Embryonic Stem Cells (HESC) Market Segment by Type
10.1 Global Human Embryonic Stem Cells (HESC) Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Human Embryonic Stem Cells (HESC) Sales and Market Share by Type (2013-2018)
10.1.2 Global Human Embryonic Stem Cells (HESC) Revenue and Market Share by Type (2013-2018)
10.2 Totipotent Stem Cells Sales Growth and Price
10.2.1 Global Totipotent Stem Cells Sales Growth (2013-2018)
10.2.2 Global Totipotent Stem Cells Price (2013-2018)
10.3 Pluripotent Stem Cells Sales Growth and Price
10.3.1 Global Pluripotent Stem Cells Sales Growth (2013-2018)
10.3.2 Global Pluripotent Stem Cells Price (2013-2018)
10.4 Unipotent Stem Cells Sales Growth and Price
10.4.1 Global Unipotent Stem Cells Sales Growth (2013-2018)
10.4.2 Global Unipotent Stem Cells Price (2013-2018)
11 Global Human Embryonic Stem Cells (HESC) Market Segment by Application
11.1 Global Human Embryonic Stem Cells (HESC) Sales Market Share by Application (2013-2018)
11.2 Research Sales Growth (2013-2018)
11.3 Clinical Trials Sales Growth (2013-2018)
11.4 Others Sales Growth (2013-2018)
12 Human Embryonic Stem Cells (HESC) Market Forecast (2018-2023)
12.1 Global Human Embryonic Stem Cells (HESC) Sales, Revenue and Growth Rate (2018-2023)
12.2 Human Embryonic Stem Cells (HESC) Market Forecast by Regions (2018-2023)
12.2.1 North America Human Embryonic Stem Cells (HESC) Market Forecast (2018-2023)
12.2.2 Europe Human Embryonic Stem Cells (HESC) Market Forecast (2018-2023)
12.2.3 Asia-Pacific Human Embryonic Stem Cells (HESC) Market Forecast (2018-2023)
12.2.4 South America Human Embryonic Stem Cells (HESC) Market Forecast (2018-2023)
12.2.5 Middle East and Africa Human Embryonic Stem Cells (HESC) Market Forecast (2018-2023)
12.3 Human Embryonic Stem Cells (HESC) Market Forecast by Type (2018-2023)
12.3.1 Global Human Embryonic Stem Cells (HESC) Sales Forecast by Type (2018-2023)
12.3.2 Global Human Embryonic Stem Cells (HESC) Market Share Forecast by Type (2018-2023)
12.4 Human Embryonic Stem Cells (HESC) Market Forecast by Application (2018-2023)
12.4.1 Global Human Embryonic Stem Cells (HESC) Sales Forecast by Application (2018-2023)
12.4.2 Global Human Embryonic Stem Cells (HESC) Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Human Embryonic Stem Cells (HESC) Picture
Table Product Specifications of Human Embryonic Stem Cells (HESC)
Figure Global Sales Market Share of Human Embryonic Stem
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
